Chapter 7 140 67. Mao M, Ai F, Zhang Y, et al. Changes in the symptoms and quality of life of women with symptomatic pelvic organ prolapse fitted with a ring with support pessary. Maturitas 2018;117:51-6. 68. Sansone S, Sze C, Eidelberg A, et al. Role of Pessaries in the Treatment of Pelvic Organ Prolapse: A Systematic Review and Meta-analysis. Obstet Gynecol 2022;140:613-22. 69. Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: Updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2011;154:291-2. 70. Li FG, Maheux-Lacroix S, Deans R, et al. Effect of Fractional Carbon Dioxide Laser vs Sham Treatment on Symptom Severity in Women With Postmenopausal Vaginal Symptoms: A Randomized Clinical Trial. JAMA 2021;326:1381-9. 71. Page AS, Verbakel JY, Verhaeghe J, Latul YP, Housmans S, Deprest J. Laser versus sham for genitourinary syndrome of menopause: A randomised controlled trial. BJOG 2023;130:312-9. 72. Mackova K, Mazzer AM, Mori Da Cunha M, et al. Vaginal Er:YAG laser application in the menopausal ewe model: a randomised estrogen and sham-controlled trial. BJOG 2021;128:108796. 73. Thys SD, Roovers JP, Geomini PM, Bongers MY. Do patients prefer a pessary or surgery as primary treatment for pelvic organ prolapse. Gynecol Obstet Invest 2012;74:6-12. 74. Clemons JL, Aguilar VC, Sokol ER, Jackson ND, Myers DL. Patient characteristics that are associated with continued pessary use versus surgery after 1 year. Am J Obstet Gynecol 2004;191:159-64. 75. Cichowski S, Grzybowska ME, Halder GE, et al. International Urogynecology Consultation: Patient Reported Outcome Measures (PROs) use in the evaluation of patients with pelvic organ prolapse. Int Urogynecol J 2022;33:2603-31. 76. Gambacciani M, Cervigni M, Gaspar A, et al. Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years. Climacteric 2020;23:S28-s32. 77. Milsom I, Gyhagen M. The prevalence of urinary incontinence. Climacteric 2019;22:217-22. 78. Richter HE, Burgio KL, Brubaker L, et al. Continence pessary compared with behavioral therapy or combined therapy for stress incontinence: a randomized controlled trial. Obstet Gynecol 2010;115:609-17. 79. Dumoulin C, Cacciari LP, Hay‐Smith EJC. Pelvic floor muscle training versus no treatment, or inactive control treatments, for urinary incontinence in women. Cochrane Database Syst Rev 2018. 80. Bø K, Hilde G. Does it work in the long term?--A systematic review on pelvic floor muscle training for female stress urinary incontinence. Neurourol Urodyn 2013;32:215-23. 81. Ogah J, Cody JD, Rogerson L. Minimally invasive synthetic suburethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev 2009. 82. da Fonseca LC, Giarreta FBA, Peterson TV, et al. A randomized trial comparing vaginal laser therapy and pelvic floor physical therapy for treating women with stress urinary incontinence. Neurourol Urodyn 2023. 83. Blaganje M, Šćepanović D, Žgur L, Verdenik I, Pajk F, Lukanović A. Non-ablative Er:YAG laser therapy effect on stress urinary incontinence related to quality of life and sexual function: A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol 2018;224:153-8. 84. Seki AS, Bianchi-Ferraro A, Fonseca ESM, Sartori MGF, Girão M, Jarmy-Di Bella ZIK. CO(2) Laser and radiofrequency compared to a sham control group in treatment of stress urinary incontinence (LARF study arm 3). A randomized controlled trial. Int Urogynecol J 2022;33:3535-42. 85. Lauterbach R, Aharoni S, Justman N, Farago N, Gruenwald I, Lowenstein L. The efficacy and safety of a single maintenance laser treatment for stress urinary incontinence: a double-blinded randomized controlled trial. Int Urogynecol J 2022;33:3499-504. 86. Alexander JW, Karjalainen P, Ow LL, et al. CO(2) surgical laser for treatment of stress urinary incontinence in women: a randomized controlled trial. Am J Obstet Gynecol 2022;227:473.e1-.e12. 87. O'Reilly BA, Viereck V, Phillips C, et al. Vaginal erbium laser treatment for stress urinary incontinence: A multicenter randomized sham-controlled clinical trial. Int J Gynaecol Obstet 2023. 88. Temtanakitpaisan T, Chongsomchai C, Buppasiri P. Fractional CO(2) laser treatment for women with stress predominant urinary incontinence: a randomized controlled trial. Int Urogynecol J 2023;34:2827-32. 89. Valderrama V, Collins SA, Swift S, et al. Joint report on the terminology for surgical procedures to treat stress urinary incontinence in women. International Urogynecology Journal 2020;31:465-78. 90. Sandvik H, Espuna M, Hunskaar S. Validity of the incontinence severity index: comparison with pad-weighing tests. Int Urogynecol J Pelvic Floor Dysfunct 2006;17:520-4.
RkJQdWJsaXNoZXIy MTk4NDMw